Justice Department Clears Cigna-Express Scripts Deal

Cigna's deal for Express Scripts came on the heels of CVS Health Corp.'s about $68 billion deal to buy insurer Aetna Inc., which is still under review. That combination would unite the U.S. drugstore giant with the third-biggest health insurer. CVS also manages drug-benefits plans for employers and insurers, a business that could help steer Aetna's customers into CVS drugstores when they fill a prescription.

While a combined Cigna-Express Scripts would have substantial bargaining power over drug prices, it remains to be seen whether that muscle would reduce costs for the employers and patients who ultimately pay the bill.

Ana Gupte, an analyst at Leerink Partners, said approval of the Express Scripts deal is a positive sign for CVS and Aetna. That's because it indicates that the Justice Department likely isn't concerned about consolidation among insurers and pharmacy-benefit managers, which aren't direct competitors.

Bloomberg reported earlier this month that CVS and Aetna are in talks with the Justice Department about divesting Medicare prescription-drug plans to resolve the government's concerns the deal would harm competition.

The Justice Department didn't put any conditions on the Cigna-Express Scripts deal, the companies said in a joint statement.

"We are pleased that the Department of Justice has cleared our transaction and that we are another step closer to completing our merger and delivering greater affordability, choice and predictability to our customers and clients as a combined company," Cigna's Chief Executive Officer David Cordani said in a statement.

— Read Icahn Drops Fight to Block Cigna's Express Scripts Deal, on ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on LinkedIn and Twitter.